Abstract:Background & Aims Natural killer (NK) cells are key players in tumor immunosurveillance and metabolic adaption manipulates their fate and functional state. The nicotinamide adenine dinucleotide (NAD+) has emerged as a vital factor to link cellular metabolism and signaling transduction. Here, we identified NAD+ metabolism as a central hub to determine the homeostasis and function of NK cells. Approach & Results NAD+ level was elevated in activated NK cells. NAD+ supplementation not only enhanced cytokine production and cytotoxicity, but also improved the proliferation and viability of NK cells. Intriguingly, the salvage pathway was involved in maintaining NAD+ homeostasis in activated NK cells. Genetic ablation or pharmacological blockade of nicotinamide phosphoribosyltransferase (NAMPT), the rate‐limiting enzyme in the NAD+ salvage pathway, markedly destroyed the viability and function of NK cells. Mechanistically, NAD+ salvage dictated the mitochondrial homeostasis and oxidative phosphorylation activity to support the optimal function of NK cells. However, in human hepatocellular carcinoma (HCC) tissues, NAMPT expression and NAD+ level were significantly downregulated in tumor‐infiltrating NK cells (TINKs), which negatively correlated with patient survival. And, lactate accumulation in tumor microenvironment was at least partially responsible for the transcriptional repression of NAMPT in NK cells. Further, deficiency of Nampt in NK cells accelerated the growth of HCC and melanoma. Supplementation of NAD+ precursor, nicotinamide mononucleotide (NMN), significantly improved NK anti‐tumor response in both mouse and human cell‐derived xenograft. Conclusions These findings reveal NAD+ salvage as an essential factor for NK cell homeostasis and function, suggesting a potential strategy for invigorating NK cell‐based immunotherapy.

NAD+ Treatment Induces Tumor Cell Necrosis by P2X7 Receptor‐Independent Pathways

NAD+ Treatment Decreases Tumor Cell Survival by Inducing Oxidative Stress.

Nadh Can Induce Necrosis of C6 Glioma Cells and Neuro2a Cells

NADPH Treatment Induces Profound Necrosis of C6 Glioma Cells

Nad+ Induces C6 Glioma Cell Death by Generating Oxidative Stress and Increasing Intracellular Calcium Concentrations

NAD+ Induces Autophagy of Neuro2a Cells by Increasing Oxidative Stress

NAD+ Treatment Induces Delayed Autophagy in Neuro2a Cells Partially by Increasing Oxidative Stress

NAD+ Treatment Can Prevent Multiple Rotenone‐induced Apoptotic Changes of PC12 Cells

NAD+ Treatment Can Block Rotenone‐induced Nuclear Apoptotic Changes of PC12 Cells

Targeting NAD+ Metabolism: Dual Roles in Cancer Treatment

NAD+ Treatment Can Prevent Rotenone-Induced Increases in DNA Damage, Bax Levels and Nuclear Translocation of Apoptosis-Inducing Factor in Differentiated PC12 Cells

NAD+ administration decreases doxorubicin-induced liver damage of mice by enhancing antioxidation capacity and decreasing DNA damage

NAD+ Treatment Prevents Rotenone-Induced Apoptosis and Necrosis of Differentiated PC12 Cells

Progress in phytochemicals′ induction of autophagic cell death in cancer cells and regulation of nuclear receptors

NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells

NAD+ salvage governs mitochondrial metabolism invigorating NK cell anti‐tumor immunity

Unexpected Photocatalytic Degeneration of NAD + for Inducing Apoptosis of Hypoxia Cancer Cells

Activation of P2X7 Receptor Can Lead to NAD+ Release from Astrocytes

Nicotinamide Mononucleotide Can Decrease Rotenone‐Induced Necrosis and Apoptotic Changes of Neuro2a Cells

Nad Plus Treatment Can Attenuate The Oxidative Stress-Induced, Parp-Mediated Atp Depletion In Pc12 Cells

Delayed Treatment of NAD+ Can Restore Intracellular ATP Levels and Prevent PC12 Cell Death Induced by Oxidative Stress